Table 1.
Baseline Clinical Characteristics of the Patients Before Surgery (n=128)
| Characteristics | N (%) |
|---|---|
| Age, years | 56.9±10.9 |
| Range | 32.0–80.0 |
| Gender | |
| Male | 79 (61.7%) |
| Female | 49 (38.3%) |
| Hepatitis | |
| Negative | 39 (30.5%) |
| HBV (+) | 83 (64.8%) |
| HCV (+) | 6 (4.7%) |
| ECOG performance status | |
| PS 0 | 99 (77.3%) |
| PS 1 | 21 (16.4%) |
| PS 2 | 8 (6.2%) |
| Child–Pugh | |
| A | 100 (78.1%) |
| B | 28 (21.9%) |
| Serum AFP level | |
| <400 ng/mL | 86 (67.2%) |
| ≥400 ng/mL | 42 (32.8%) |
| Number of tumors | |
| Solitary | 116 (90.6%) |
| Multiple | 12 (9.4%) |
| Size of tumor | 8.4 (± 3.9) |
| ≤5 cm | 36(28%)) |
| 5–10 cm | 51(40%) |
| >10 cm | 41(32%) |
| BCLC stage | |
| A | 81 (63.3%) |
| B | 18 (14.1%) |
| C | 29 (22.7%) |
Abbreviations: ECOG, Eastern Cooperative Oncology Group; AFP, alpha fetal protein; BCLC, Barcelona Clinic Liver Cancer.